[HTML][HTML] Human disease models in drug development

A Loewa, JJ Feng, S Hedtrich - Nature reviews bioengineering, 2023 - nature.com
Biomedical research is undergoing a paradigm shift towards approaches centred on human
disease models owing to the notoriously high failure rates of the current drug development …

Human disease models in drug development

A Loewa, J Feng, S Hedtrich - Nature Reviews Bioengineering, 2023 - europepmc.org
Biomedical research is undergoing a paradigm shift towards approaches centred on human
disease models owing to the notoriously high failure rates of the current drug development …

[PDF][PDF] Human disease models in drug development

A Loewa, JJ Feng, S Hedtrich - edisciplinas.usp.br
Biomedical research is undergoing a paradigm shift towards approaches centred on human
disease models owing to the notoriously high failure rates of the current drug development …

[HTML][HTML] Human disease models in drug development

A Loewa, JJ Feng, S Hedtrich - Nature Reviews Bioengineering - ncbi.nlm.nih.gov
Biomedical research is undergoing a paradigm shift towards approaches centred on human
disease models owing to the notoriously high failure rates of the current drug development …

Human disease models in drug development

A Loewa, JJ Feng, S Hedtrich - Nature Reviews Bioengineering, 2023 - edoc.mdc-berlin.de
Biomedical research is undergoing a paradigm shift towards approaches centred on human
disease models owing to the notoriously high failure rates of the current drug development …

Human disease models in drug development

A Loewa, JJ Feng, S Hedtrich - Nature reviews bioengineering - pubmed.ncbi.nlm.nih.gov
Biomedical research is undergoing a paradigm shift towards approaches centred on human
disease models owing to the notoriously high failure rates of the current drug development …

Human disease models in drug development.

A Loewa, JJ Feng, S Hedtrich - Nature Reviews Bioengineering, 2023 - europepmc.org
Biomedical research is undergoing a paradigm shift towards approaches centred on human
disease models owing to the notoriously high failure rates of the current drug development …